517.70
-0.50
(-0.10%)
At close: January 30 at 5:32:09 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 17 | 16 | 22 | 23 |
| Avg. Estimate | 111.64B | 112.46B | 452.34B | 485.61B |
| Low Estimate | 109.26B | 110.63B | 441.88B | 462.74B |
| High Estimate | 113.91B | 113.54B | 457.42B | 498.6B |
| Year Ago Sales | 99.8B | 98.86B | 400.28B | 452.34B |
| Sales Growth (year/est) | 11.86% | 13.76% | 13.01% | 7.35% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| UNH.VI | -- | -- | -- | -- |
| S&P 500 | 9.01% | 10.57% | 14.00% | 13.70% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Overweight to Overweight | 1/28/2025 |
| Maintains | Barclays: Overweight to Overweight | 1/17/2025 |
| Reiterates | Keybanc: Overweight to Overweight | 1/17/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 1/17/2025 |
| Maintains | Truist Securities: Buy to Buy | 1/6/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 1/2/2025 |